-
Genetic variations in a fourth gene linked to elevated leukemia risk in Hispanic children
02/14/2019
Progress reported on understanding why Hispanic children are more likely to develop acute lymphoblastic leukemia and to die of the disease.
-
St. Jude Children’s Research Hospital named to Fortune magazine’s “100 Best Companies to Work For’ for ninth consecutive year
02/14/2019
The institution is the highest-ranked Memphis-based organization; for nearly a decade, Fortune has recognized the hospital’s commitment to employee
-
St. Jude Children’s Research Hospital honored as recipient of the 2019 Microsoft Health Innovation Awards
02/13/2019
St. Jude Children’s Research Hospital announced it has been named a recipient of Microsoft Corp.’s 2019 Health Innovation Awards.
-
Customized drug interaction alerts address alert fatigue, protect patients
02/13/2019
Researchers developed a method for customizing and reducing drug interaction alerts in electronic health records for pediatric cancer patients.
-
St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences launches Master of Science degree program
02/04/2019
New program will integrate traditional training and experiential learning at St. Jude campus and partner site.
-
St. Jude researchers discover key genomic 'management' partners in brain development
02/04/2019
The study reports how two unexpected partners, the proteins UTX and 53BP1, link up to regulate a brain development program comprising hundreds of genes.
-
St. Jude collaboration offers research road map to improve pediatric patient care
01/23/2019
Survey results should help health system leaders and patient safety experts dedicate resources to improve safety and clinical outcomes in pediatric health care.
-
No substantial benefit from transplantation reported for a high-risk leukemia subtype
01/18/2019
Children with hypodiploid acute lymphoblastic leukemia fare better when minimal residual disease is used to guide treatment.
-
More accurate leukemia diagnosis expected as researchers refine leukemia classification
01/14/2019
Research led by St. Jude Children's Research Hospital means more than 90 percent of the most common cases of childhood cancer can now be classified by subtype, an advance likely to fuel precision medicine.
-
Research reveals machinery of a deadly childhood brain cancer
12/27/2018
Investigators studied the effects of the H3 K27M mutation, and revealed its impact on mutations that are known drivers of DIPGs.
-
Newly identified subset of immune cells may be key to fighting chronic inflammation
12/20/2018
Read about the newly identified subset of helper T 17 immune cells that suggest a novel approach for taming chronic inflammation.
-
Researchers report how molecular partners form dynamic scaffolding for protein machinery
12/05/2018
Scientific discovery by St. Jude group could lead to new pathway for cancer treatment and understanding of ALS.
-
St. Jude research into leukemia, sickle cell and other blood disorders presented at ASH
11/30/2018
The 2018 annual meeting of the American Society of Hematology will include research from St. Jude that stretches from the laboratory to the clinic.
-
St. Jude at the American Society of Hematology (ASH) 2018 annual meeting
11/28/2018
St. Jude scientists and clinicians highlighted at the annual American Society of Hematology in San Diego. Read the latest.
-
St. Jude announces extensive resource to advance leukemia research
11/14/2018
The Public Resource of Patient-derived and Expanded Leukemias (PROPEL) offers patient-derived xenograft samples free of charge for researchers worldwide.
-
Researchers reveal why Hippo pathway may have an outsized effect on solid tumor
10/30/2018
A surprising mechanism that might explain how the Hippo signaling pathway promotes solid tumor growth.
-
Small risks may have big impact on breast cancer odds of childhood cancer survivors
10/26/2018
Common genetic variations may help find female childhood cancer survivors at increased risk of breast cancer and who are candidates for stepped up screening.
-
Obesity problem starts early phase of therapy in children with acute lymphoblastic leukemia
10/25/2018
Children with ALL gain weight during treatment, and researchers suggest that early interventions should be considered.
-
Collaboration yields possible treatment for rare neurodegenerative disorder
10/23/2018
Read how a discovery in bacteria in the 1980s led to a promising new class of compounds for treatment of PKAN, a progressive neurodegenerative disease.
-
St. Jude investigators present novel pediatric cancer genome sequencing data at ASHG
10/17/2018
Presentations outline data from Genomes for Kids study, proving clinical utility of multi-platform genome sequencing for pediatric precision oncology.
-
Researchers find a ‘critical need’ for whole genome sequencing of young cancer patients
10/11/2018
Including whole-genome sequencing into clinical genomic testing found cancer-driving mutations other sequencing methods failed to identify.
-
St. Jude researchers awarded grant to lead pharmacogenetics implementation efforts
10/04/2018
The funding will support CPIC, which provides guidelines to help clinicians understand how genetic test results should be used to optimize drug therapy.
-
World Health Organization, St. Jude Children’s Research Hospital collaborate against childhood cancer
09/27/2018
New global childhood cancer effort aims to cure at least 60 percent of children with six of the most common kinds of cancer worldwide by 2030.
-
Method identified to reduce risk of brain damage in leukemia survivors
09/24/2018
St. Jude scientists have discovered a link between sepsis during cancer treatment and long-term neurocognitive dysfunction.
-
What can salad dressing tell us about cancer? Think oil and vinegar.
09/20/2018
Evidence suggests liquid phase separation, a process that explains why oil and water separate, may contribute to cancer, including prostate cancer.
-
High-resolution genomic map gives scientists unprecedented view of brain development
09/13/2018
The research will aid basic understanding of brain development, and also help understanding cellular origins of brain disorders caused by errors in development.
-
Discovery of a cancer promoter offers pathway to overcome drug resistance
09/12/2018
Geneticists discovered that mTORC3 aids cancers' resistance to rapamycin and related drugs, offering the promise of new drug therapies to treat cancers.
-
St. Jude researchers solve a central mystery of a baffling high-risk leukemia
09/12/2018
Read the latest on the roots of mixed phenotype acute leukemia (MPAL), including how the findings might affect treatment of patients with the high-risk cancer.
-
CBS Sports HQ To Stream Live Fantasy Football Telethon on Labor Day
08/28/2018
CBS Sports HQ will partner with St. Jude to support Childhood Cancer Awareness Month by streaming a live Fantasy Football Telethon on Labor Day.
-
Immune system prioritizes distinct immune responses in infants with flu
08/28/2018
Flu infections pose a significant risk to infants. Read about the T cells the immune system relies on to repair lung damage in infants infected with influenza.
